Leyden Labs (private company)

See something wrong or missing? Let us know
Offices:Amsterdam
Business model:B2B

Leyden Laboratories aims to protect against a broad range of viruses via a platform used to target commonalities of viral families to protect against many viruses simultaneously as opposed to vaccines that typically protect against a specific virus variant.

Investors: we tracked 11 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 294.03M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Leyden Labs

Name Criteria
Germany Atai Life Sciences
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 7
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden EnginZyme
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Sano Genetics
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 5
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Mogrify
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 6
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Ochre Bio
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 7
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom bit.bio
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Synthace
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 6
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Italy Kither Biotech
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 5
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Epitopea
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top